BIOXCEL SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In BioXcel To Contact Him Directly To Discuss Their Options

NEW YORK, Aug. 19, 2023 /PRNewswire/ — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against BioXcel Therapeutics, Inc. (“BioXcel” or the “Company”) (NASDAQ: BTAI) and reminds investors of the September 5, 2023 deadline to seek the role…

About the Author

has written 20663 stories on this site.

Copyright © 2010-2019 strategicbusinessnews.com